The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution.

Bone Marrow Transplant

Section of Hematology and Medical Oncology, Department of Medicine, Boston Medical Center, Boston, MA, USA.

Published: September 2017

Download full-text PDF	Source
http://dx.doi.org/10.1038/bmt.2017.148	DOI Listing

Publication Analysis

incidence atrial

atrial fibrillation

fibrillation patients

patients amyloidosis

amyloidosis undergoing

undergoing high-dose

high-dose melphalan

melphalan stem

stem cell

cell transplantation

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!